Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Myeloid, Accelerated Phase 2Blast Crisis 2Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Dasatinib 4nilotinib 3Imatinib Mesylate 3ruxolitinib 2bosutinib 2Tacrolimus 2Mycophenolic Acid 2Methotrexate 2Cyclosporine 2Cyclophosphamide 2venetoclax 1ponatinib 1pembrolizumab 1letermovir 1fludarabine phosphate 1asciminib 1Whole-Body Irradiation 1Vorinostat 1Valganciclovir 1Tyrosine Kinase Inhibitors 1Therapeutics 1Specimen Handling 1Sirolimus 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Ganciclovir 1Foscarnet 1Flow Cytometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myeloid, Chronic-Phase × ponatinib × Clear all
NCT04160546 2024-12-31

ResToP

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Active not recruiting
80 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡